www.justice.gov/opa/pr/pharmaceutical-giant-astrazeneca-pay-520-million-label-drug-marketing

Apr 27, 2010 ... AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the .... will be disclosed -- all leading to better protection for patients," said Department of ...

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb .... Third, he contends defendants knowingly conspired with Medco and others to violate ...

casetext.com/case/united-states-v-astrazeneca-biopharmaceuticals-inc

Apr 17, 2017 ... Astrazeneca Biopharmaceuticals, Inc. ... PLC; Astrazeneca, LP; and Astrazeneca Pharmaceuticals, LP (together, ... AstraZeneca, et al., No.

www.bloomberg.com/news/articles/2017-11-17/astrazeneca-in-talks-to-settle-texas-lawsuit-over-sales-tactics

Nov 17, 2017 ... AstraZeneca Plc is in talks to settle a Texas lawsuit claiming that the company fleeced the state's Medicaid program by fraudulently marketing ...

www.bloomberg.com/news/articles/2018-08-07/astrazeneca-to-pay-110-million-to-settle-texas-drug-suits-jkk6v647

Aug 7, 2018 ... AstraZeneca Plc agreed to pay $110 million to settle a Texas claim alleging that the ... by fraudulently marketing two medications, according to the state's attorney general office. ... The case is the State of Texas v. AstraZeneca LP, No. ... Trademarks Privacy Policy ©2019 Bloomberg L.P. All Rights Reserved.